My experience owning a 250-client home health agency taught me a lot about how people age and die in our society. I knew then that our home health care aides worked to the best of their ability to stave off loneliness, depression and anxiety over the fear of dying, but often their compassionate care was not enough. Fast forward to three years ago when I began to study the benefits of psychedelic care. I was drawn to the research using psilocybin in cancer patients that showed significant reductions in anxiety and depression while also helping participants accept their death and dying with peace and equanimity. Along the way, I dove into the benefits of Ketamine and MDMA, as well, and realized that bringing safe, psychedelic care to those with life-threatening or terminal illnesses would become my life’s work. As a result, I founded the nonprofit, End of Life Psychedelic Care, to educate and provide patients with access to compassionate care and support during the end-of-life process. We believe that psychedelic-assisted care can play a pivotal role in easing anxiety, depression, as well as the emotional and spiritual challenges that often accompany a life-threatening or terminal illness.